Acer Medical (ROCO:6857) Beginning Cash Position: NT$176.15 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6857 Acer Medical Inc ROCO:6857
56 GF Score
Price NT$90.00
GF Value NT$217.25
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Acer Medical Beginning Cash Position?

Acer Medical ROCO:6857 -0.55% 56 Beginning Cash Position is NT$176.15 Mil as of Jun. 2026. GuruFocus rates ROCO:6857 with a GF Score™ of 56/100 and a GF Value™ of NT$217.25 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Acer Medical's Beginning Cash Position for the quarter that ended in Jun. 2026 was NT$176.15 Mil.

Acer Medical's quarterly Beginning Cash Position declined from Jun. 2025 (NT$202.78 Mil) to Dec. 2025 (NT$184.77 Mil) and declined from Dec. 2025 (NT$184.77 Mil) to Jun. 2026 (NT$176.15 Mil).

Acer Medical's annual Beginning Cash Position declined from Dec. 2023 (NT$276.56 Mil) to Dec. 2024 (NT$220.03 Mil) and declined from Dec. 2024 (NT$220.03 Mil) to Dec. 2025 (NT$202.78 Mil).

Acer Medical Beginning Cash Position Related Terms

Acer Medical Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Acer Medical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acer Medical Beginning Cash Position Chart

Acer Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 43.36 49.68 276.56 220.03 202.78

Acer Medical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 220.03 147.00 202.78 184.77 176.15
ROCO:6857
56GF Score
Acer Medical Inc ROCO:6857
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acer Medical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of NT$176.15 Mil mean?
Acer Medical (ROCO:6857) has a Beginning Cash Position of NT$176.15 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Acer Medical and its competitors.
Is Acer Medical's Beginning Cash Position too high?
Acer Medical's current Beginning Cash Position is NT$176.15 Mil. Overall, Acer Medical has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acer Medical's Beginning Cash Position compare to VEEV and BTSG?
Acer Medical's Beginning Cash Position of NT$176.15 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Healthcare Providers & Services company?
A good Beginning Cash Position depends on the Healthcare Providers & Services industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Acer Medical and its competitors. Acer Medical's current Beginning Cash Position is NT$176.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acer Medical stock overvalued right now?
Based on GuruFocus' analysis, Acer Medical (ROCO:6857) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$217.25, compared to a current price of NT$90.00 — trading 58.6% below its estimated fair value. The current Beginning Cash Position is NT$176.15 Mil. Acer Medical's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Acer Medical (ROCO:6857), the current Beginning Cash Position is NT$176.15 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acer Medical (ROCO:6857) Overvalued in 2026?

Based on GuruFocus' analysis, Acer Medical stock appears to be undervalued. The current stock price of NT$90.00 is trading 58.6% below its estimated GF Value™ of NT$217.25. GuruFocus considers Acer Medical to be Significantly Undervalued.

Key valuation signals for ROCO:6857:

  • Beginning Cash Position: NT$176.15 Mil
  • GF Value™: NT$217.25 vs. price of NT$90.00 (58.6% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6857 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acer Medical Business Description

Address Xintai 5th Road, 7th Floor, No. 86, Section 1, Xizhi District, New Taipei, TWN
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
56GF Score

Get the complete analysis for ROCO:6857

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$90.00
Price
NT$217.25
GF Value